Gastrointestinal diseases from epidemiology to therapeutic intervention in general practice: A cost-analysis

PharmacoEconomics - Italian Research Articles

Volumn 4, Issue 1, 2002, Pages 3-14

  Salvato, C ^a   Terrazzani, G ^a   Serraglia, D ^a   Ragazzi, E ^b   Chinellato, Alessandro ^a  

^a ULSS 9   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIULCER AGENT; BISMUTH CITRATE; CIMETIDINE; CLEBOPRIDE; DOMPERIDONE; FAMOTIDINE; GASTROINTESTINAL AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; MAGALDRATE; METOCLOPRAMIDE; MISOPROSTOL; NIZATIDINE; OMEPRAZOLE; PANTOPRAZOLE; PROSTAGLANDIN DERIVATIVE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; ROXATIDINE; SUCRALFATE;

ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; DRUG COST; DRUG INDUCED DISEASE; DRUG UTILIZATION; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE MANAGEMENT; HOSPITAL PLANNING; HUMAN; ITALY; MALE; MEDICAL RECORD; MEDICAL SPECIALIST; OUTCOMES RESEARCH; PATIENT MONITORING; PRESCRIPTION; QUESTIONNAIRE; RANDOMIZATION; STOMACH INJURY; STOMACH LESION; ULCER;

EID: 0036259266     PISSN: 15909158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03320589     Document Type: Article

References (27)

1. Clinical economics review: Gastrointestinal disease in primary care
2. L'approccio al paziente dispeptico in medicina generale
3. Stress ulcer prophylaxis: Still a valid option in the 1990s?
4. ASHP therapeutics guidelines on stress ulcer prophylaxis
5. Guidelines for ATC classification and DDD assignment
6. Cost-effectiveness analysis of different strategies for treating duodenal ulcer
7. Consensus guidelines for evaluating and treating patients with upper gastrointestinal symptoms in primary care setting
8. Symptomatic gastro-oesophageal reflux disease: Double blind controlled study of intermittent treatment with omeprazole or ranitidine
9. Novel therapeutic approaches to gastric and duodenal ulcers: An update
10. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease
11. 2-antagonists: A meta-analysis of their efficacy in treating bleeding peptic ulcer
12. Antacid (A02A) and antiulcer (A02B) drug prescription patterns: Predicting factors, dosage and treatment duration
13. Factors affecting depth of gastric ulcers
14. The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: A questionnaire survey
15. Do patients wish to be involved in decision making in the consultation? A cross sectional survey with video vignettes
16. [Farmaci antiulcera: Un'esperienza di razionalizzazione della prescrizione nell'ASL 7 del Piemonte]
17. Acid-related disease in the population of two Norwegian municipalities-diagnosis and drug therapy
18. Overuse of proton pump inhibitors
19. Modelli decisionali e farmacoeconomia. Confronto lansoprazolo vs. ranitidina nella malattia da reflusso gastroesofageo
20. Management of upper gastrointestinal disease in primary care: Controversy and consensus with outcome research
21. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease
22. The GERD outcomes trial: Effectiveness and costs of omeprazole vs ranitidine in empiric treatment of heartburn in primary care practice
23. Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease
24. Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia
25. Customising an international disease management model to the needs of individual countries. Application to upper gastrointestinal disease
26. Discontinuation of antihyperlipidemic drugs-do rates reported in clinical trials reflect rates in primary care settings?
27. From trial data to practical knowledge: Qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia